Caricamento...
Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)
BACKGROUND: People with chronic obstructive pulmonary disease (COPD) have poor quality of life, reduced survival, and accelerated decline in lung function, especially associated with acute exacerbations, leading to high healthcare costs. Long‐acting bronchodilators are the mainstay of treatment for...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2017
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481854/ https://ncbi.nlm.nih.gov/pubmed/28631387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011897.pub2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|